Simultaneous determination of paracetamol and methocarbamol in human plasma by HPLC using UV detection with time programming: Application to pharmacokinetic study

Drug Research

Volumn 64, Issue 7, 2014, Pages 363-367

  Helmy, S A ^a   El Bedaiwy, H M ^a  

^a Damanhour University   (Egypt)

Author keywords

bioequivalence; HPLC UV with time programming; methocarbamol; paracetamol; pharmacokinetics

Indexed keywords

CAFFEINE; DICLOFENAC; KETOROLAC; METHANOL; METHOCARBAMOL; PARACETAMOL; SODIUM DIHYDROGEN PHOSPHATE; THEOPHYLLINE; TINIDAZOLE; TABLET;

ABSENCE OF SIDE EFFECTS; ACCURACY; ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG MONITORING; DRUG STABILITY; ENVIRONMENTAL TEMPERATURE; FREEZE THAWING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NORMAL HUMAN; PLASMA; PRECIPITATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TIME TO MAXIMUM PLASMA CONCENTRATION; ULTRAVIOLET DETECTOR; ULTRAVIOLET RADIATION; ADOLESCENT; CHEMISTRY; PHARMACOKINETICS; PROCEDURES; TABLET; YOUNG ADULT;

ACETAMINOPHEN; ADOLESCENT; ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; LIMIT OF DETECTION; MALE; METHOCARBAMOL; TABLETS; ULTRAVIOLET RAYS; YOUNG ADULT;

EID: 84904210435     PISSN: 21949379     EISSN: 21949387     Source Type: Journal    
DOI: 10.1055/s-0033-1358703     Document Type: Article

References (14)

1. Souri E., Sharifzadeh M., Farsam H. et al. Muscle relaxant activity of methocarbamol enantiomers in mice. J Pharm Pharmacol: 1999; 51 853 855 (Pubitemid 29377959)
2. Lewis W. B. Use of methocarbamol in orthopedics. Calif Med: 1959; 90 26 28
3. Bonnefont J., Courade J. P., Alloui A. et al. Antinociceptive mechanism of action of paracetamol. Drugs: 2003; 63 1 4
4. ® Extra Strength prescribing information: WHITEHALL- ROBINS INC. MISSISSAUGA, ONTARIO L4Z 3 M6, Canada http://www.backrelief.ca/back-relief-products/robax-oral-caplets/ robaxacet-extra-strength [Accessed April 15, 2013]
5. ® prescribing information: WHITEHALL- ROBINS INC. MISSISSAUGA, ONTARIO L4Z 3 M6, Canada http://www.backrelief.ca/back- relief-products/robax-oral-caplets/robax-platinum [Accessed April 15, 2013]
6. Weng N., Lee J. W., Hulse J. D. Development and Validation of a Chiral HPLC Method for the Quantitation of Methocarbamol Enantiomers in Human Plasma. J Liq Chromatogr: 1994; 17 3747 3758
7. Gholivand M. B., Khodadadian M. Rationally designed molecularly imprinted polymers for selective extraction of methocarbamol from human plasma. Talanta: 2011; 85 1680 1688
8. Weng N., Lee J. W., Hulse J. D. Development and validation of a high-performance liquid chromatographic method for the determination of methocarbamol in human plasma. J Chromatogr B Biomed Appl: 1994; 654 287 292 (Pubitemid 24119174)
9. Alessi-Severini S., Coutts R. T., Jamali F. et al. High-performance liquid chromatographic analysis of methocarbamol enantiomers in biological fluids. J Chromatogr: 1992; 582 173 179
10. Tan Q. Y., Zhu R. H., Li H. D. et al. Simultaneous quantitative determination of paracetamol and its glucuronide conjugate in human plasma and urine by liquid chromatography coupled to electrospray tandem mass spectrometry: application to a clinical pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci: 2012; 893-894 162 167
11. Tonoli D., Varesio E., Hopfgartner G. Quantification of acetaminophen and two of its metabolites in human plasma by ultra-high performance liquid chromatography - low and high resolution tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci: 2012; 904 42 50
12. Rustum A. M. Determination of acetaminophen in human plasma by ion-pair reversed-phase high-performance liquid chromatography. Application to a single-dose pharmacokinetic study. J Chromatogr Sci: 1989; 27 18 22 (Pubitemid 19019377)
13. rd, 2013]
14. Schlegelmilch R., Eydeler A. U., Barkworth M. et al. Bioequivalence study with two different oral formulations of methocarbamol in healthy subjects. A mono-centre, comparative, randomized, open-label, single-dose, 2-way crossover study. Arzneimittelforschung: 2009; 59 238 242